Moleculin Biotech
MBRX
MBRX
24 hedge funds and large institutions have $1.58M invested in Moleculin Biotech in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
23% less capital invested
Capital invested by funds: $2.05M → $1.58M (-$479K)
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$76.9K | |
| 2 | +$43K | |
| 3 | +$36K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$26K |
| 5 |
WIC
Whitegate Investment Counselors
Concord,
New Hampshire
|
+$25.8K |
Top Sellers
| 1 | -$13K | |
| 2 | -$11K | |
| 3 | -$9.82K | |
| 4 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
-$4K |
| 5 |
AWM
Avondale Wealth Management
West Lake Hills,
Texas
|
-$4K |